Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes

CardiOmetabolic SyndroME Response to Therapeutic lIfestyle Changes

Intensive lifestyle intervention has shown to be effective in high risk patient populations and has gathered support from leaders-as outlined in the 2015 consensus paper by the Cardiometabolic Health Alliance. Thus there has been a call to establish new care models that assist Metabolic Syndrome patients in reducing there risk. The investigators aim to evaluate the impact of a lifestyle intervention program on metabolic syndrome patients.

Inclusion Criteria:

• Metabolic syndrome patients meeting 3 of 5 criteria:

  1. waist circumference (37 in) in white and AA men, (35 in) in Asian men, and (31.5 in) in women;
  2. triglycerides ≥150 mg/dl;
  3. high-density lipoprotein cholesterol (HDL-C) <40 mg/dl in men and <50 mg/dl in women;
  4. blood pressure ≥130/85 mm Hg
  5. fasting glucose ≥100 mg/d or HgbA1c ≥ 5.71 (includes diabetics)

• Patients requiring secondary ASCD prevention

Exclusion Criteria:

• Patients with less than 5 year survival
• Patients with cancer undergoing therapy or on palliative treatment
• Patients with end stage heart failure